Log In
BCIQ
Print this Print this
 

MCT-485

  Manage Alerts
Collapse Summary General Information
Company MultiCell Technologies Inc.
DescriptionDouble-stranded miRNA with direct tumor cytolytic properties
Molecular Target
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: microRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/12/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today